RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationConsultation end: 15AUG2024
Consultation end: 31JUL2024
Pharmacovigilance Risk Assessment Committee
Open for comments
From 1st June 2024
Building the AI and Digital Regulations Service
Outcomes of the EMA Management Board meeting.
18-21 March 2024
The European Medicines Agency (EMA) reminds applicants and marketing authorisation holders that adjusted fees for all applications, except for pharmacovigilance procedures, will be coming into effect on 1 April 2024.
Guidance Documents open for public consultation.